The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily

被引:598
作者
Sherwood, NM [1 ]
Krueckl, SL [1 ]
McRory, JE [1 ]
机构
[1] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada
关键词
D O I
10.1210/er.21.6.619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily includes nine hormones in humans that are related by structure, distribution (especially the brain and gut), function (often by activation of cAMP), and receptors (a subset of seven-transmembrane receptors). The nine hormones include glucagon, glucagon-like peptide-1 (GLP-1), GLP-2, glucose-dependent insulinotropic polypeptide (GIP), GH-releasing hormone (GRF), peptide histidine-methionine (PHM), PACAP, secretin, and vasoactive: intestinal polypeptide (VIP). The origin of the ancestral superfamily members is at least as old as the invertebrates; the most ancient and tightly conserved members are PACAP and glucagon. Evidence to date suggests the superfamily began with a gene or exon duplication and then continued to diverge with some gene duplications in vertebrates. The function of PACAP is considered in detail because it is newly (1989) discovered; it is tightly conserved (96% over 700 million years); and it is probably the ancestral molecule. The diverse functions of PACAP include regulation of proliferation, differentiation, and apoptosis in some cell populations. In addition, PACAP regulates metabolism and the cardiovascular, endocrine, and immune systems, although the physiological event(s) that coordinates PACAP responses remains to be identified.
引用
收藏
页码:619 / 670
页数:52
相关论文
共 647 条
  • [1] VASCULAR EFFECTS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE - A COMPARISON WITH VASOACTIVE-INTESTINAL-PEPTIDE
    ABSOOD, A
    CHEN, D
    WANG, ZY
    HAKANSON, R
    [J]. REGULATORY PEPTIDES, 1992, 40 (03) : 323 - 329
  • [2] CLONING AND FUNCTIONAL-CHARACTERIZATION OF THE HUMAN VASOACTIVE-INTESTINAL-PEPTIDE (VIP)-2 RECEPTOR
    ADAMOU, JE
    AIYAR, N
    VANHORN, S
    ELSHOURBAGY, NA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (02) : 385 - 392
  • [3] BIOACTIVITY OF GROWTH-HORMONE RELEASING HORMONE (1-29) ANALOGS AFTER SC INJECTION IN MAN
    AITMAN, TJ
    RAFFERTY, B
    COY, D
    LYNCH, SS
    CLAYTON, RN
    [J]. PEPTIDES, 1989, 10 (01) : 1 - 4
  • [4] A cloned frog vasoactive intestinal polypeptide pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals
    Alexandre, D
    Anouar, Y
    Jegou, S
    Fournier, A
    Vaudry, H
    [J]. ENDOCRINOLOGY, 1999, 140 (03) : 1285 - 1293
  • [5] Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion
    Alpini, G
    Glaser, S
    Robertson, W
    Rodgers, RED
    Phinizy, JL
    Lasater, J
    LeSage, GD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 272 (05): : G1064 - G1074
  • [6] ANDREWS PC, 1985, J BIOL CHEM, V260, P3910
  • [7] VASORELAXANT EFFECT OF PACAP-27 ON CANINE CEREBRAL-ARTERIES AND RAT INTRACEREBRAL ARTERIOLES
    ANZAI, M
    SUZUKI, Y
    TAKAYASU, M
    KAJITA, Y
    MORI, Y
    SEKI, Y
    SAITO, K
    SHIBUYA, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 285 (02) : 173 - 179
  • [8] Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells .2. Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide
    Aoki, Y
    Iwasaki, Y
    Katahira, M
    Oiso, Y
    Saito, H
    [J]. ENDOCRINOLOGY, 1997, 138 (05) : 1930 - 1934
  • [9] TISSUE DISTRIBUTION OF PACAP AS DETERMINED BY RIA - HIGHLY ABUNDANT IN THE RAT-BRAIN AND TESTES
    ARIMURA, A
    SOMOGYVARIVIGH, A
    MIYATA, A
    MIZUNO, K
    COY, DH
    KITADA, C
    [J]. ENDOCRINOLOGY, 1991, 129 (05) : 2787 - 2789
  • [10] PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND ITS RECEPTORS - NEUROENDOCRINE AND ENDOCRINE INTERACTION
    ARIMURA, A
    SHIODA, S
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 1995, 16 (01) : 53 - 88